Chinese Medical Journal (Jan 2025)

De novo patients with high-volume metastatic hormone-sensitive prostate cancer can benefit from the addition of docetaxel to triplet therapy: Network-analysis and systematic review

  • Hanxu Guo,
  • Chengqi Jin,
  • Li Ding,
  • Jun Xie,
  • Jing Xu,
  • Ruiliang Wang,
  • Hong Wang,
  • Changcheng Guo,
  • Jiansheng Zhang,
  • Bo Peng,
  • Xudong Yao,
  • Jing Yuan,
  • Bin Yang,
  • Sihan Zhou

DOI
https://doi.org/10.1097/CM9.0000000000003311
Journal volume & issue
Vol. 138, no. 2
pp. 231 – 233

Abstract

Read online

No abstracts available.